180 Sales of veterinary antimicrobial agents in 30 European countries in 2016. Trends from 2010 to 2016 8th ESVAC report by European Surveillance of Veterinary Antimic (Industry Innovation)

180 Industry Innovation – Sales of veterinary antimicrobial agents in 30 European countries in 2016. Trends from 2010 to 2016 8th ESVAC report by European Surveillance of Veterinary Antimic

AMU reduction strategies \ Monitoring and surveillance Antibiotic use
Species targeted: Pigs; Poultry; Dairy; Beef; Sheep;
Age: Different for different species;
Summary:
The 8th ESVAC report presents data on the sales of veterinary antimicrobials from 30 European countries in 2016. The report describes changes in consumption of veterinary antimicrobials for the years 2010-2016 and focuses on the changes across time in each country. Explanations for the possible reasons for the changes in the various ESVAC participating countries have been provided. The Antimicrobial Advice ad hoc Expert Group (AMEG) categories take into account the World Health Organization (WHO) categorisation of antimicrobials, the consumption of those antimicrobials in veterinary medicine, the hazards of zoonotic relevance in Europe and the risk of resistance transfer to humans. Category 2 of the AMEG categorisation includes those veterinary antimicrobials where the risk for public health is estimated to be higher than other classes of antimicrobials – fluoroquinolones, 3rd- and 4th-generation cephalosporins and polymyxins. Macrolides are not included in Category 2 and a revision of the classification of AMEG is currently ongoing.

Where to find the original material: https://www.ema.europa.eu/en/documents/report/sales-veterinary-antimicrobial-agents-30-european-countries-2016-trends-2010-2016-eighth-esvac_en.pdf;
Country: EU